-
1
-
-
84868157585
-
Unintended effects of orphan product designation for rare neurological diseases
-
Murphy, S. M., Puwanant, A. & Griggs, R. C. Unintended effects of orphan product designation for rare neurological diseases. Ann. Neurol. 72, 481-490 (2012
-
(2012)
Ann. Neurol
, vol.72
, pp. 481-490
-
-
Murphy, S.M.1
Puwanant, A.2
Griggs, R.C.3
-
2
-
-
84864127384
-
Ethical considerations in orphan drug approval and use
-
Kesselheim, A. S. Ethical considerations in orphan drug approval and use. Clin. Pharmacol. Ther. 92, 153-155 (2012
-
(2012)
Clin. Pharmacol. Ther
, vol.92
, pp. 153-155
-
-
Kesselheim, A.S.1
-
3
-
-
84865193829
-
Treatment for mitochondrial disorders
-
Art. No.: CD004426.
-
Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D. & Chinnery, P. F. Treatment for mitochondrial disorders. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004426. http://dx.doi.org/10.1002/14651858. CD004426.pub3.
-
Cochrane Database of Systematic Reviews
, Issue.4
-
-
Pfeffer, G.1
Majamaa, K.2
Turnbull, D.M.3
Thorburn, D.4
Chinnery, P.F.5
-
4
-
-
0028850504
-
Primary and secondary carnitine deficiency syndromes
-
Pons, R. & De Vivo, D. C. Primary and secondary carnitine deficiency syndromes. J. Child. Neurol. 10 (Suppl. 2), S8-S24 (1995
-
(1995)
J. Child. Neurol
, vol.10
, Issue.SUPPL. 2
-
-
Pons, R.1
De Vivo, D.C.2
-
5
-
-
0030020607
-
Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome
-
Majamaa, K., Rusanen, H., Remes, A. M., Pyhtinen, J. & Hassinen, I. E. Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome. Life Sci. 58, 691-699 (1996
-
(1996)
Life Sci
, vol.58
, pp. 691-699
-
-
Majamaa, K.1
Rusanen, H.2
Remes, A.M.3
Pyhtinen, J.4
Hassinen, I.E.5
-
6
-
-
0019596345
-
Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome
-
Lou, H. C. Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome. Arch. Neurol. 38, 469 (1981
-
(1981)
Arch. Neurol
, vol.38
, pp. 469
-
-
Lou, H.C.1
-
7
-
-
0024452528
-
The pharmacology of dichloroacetate
-
Stacpoole, P. W. The pharmacology of dichloroacetate. Metabolism 38, 1124-1144 (1989
-
(1989)
Metabolism
, vol.38
, pp. 1124-1144
-
-
Stacpoole, P.W.1
-
8
-
-
0027248848
-
Treatment of complex I deficiency with riboflavin
-
Bernsen, P. L., Gabreëls, F. J., Ruitenbeek, W. & Hamburger, H. L. Treatment of complex I deficiency with riboflavin. J. Neurol. Sci. 118, 181-187 (1993
-
(1993)
J. Neurol. Sci
, vol.118
, pp. 181-187
-
-
Bernsen, P.L.1
Gabreëls, F.J.2
Ruitenbeek, W.3
Hamburger, H.L.4
-
9
-
-
0029086146
-
Function of coenzyme Q in the cell: Some biochemical and physiological properties
-
Rauchová, H., Drahota, Z. & Lenaz, G. Function of coenzyme Q in the cell: Some biochemical and physiological properties. Physiol. Res. 44, 209-216 (1995
-
(1995)
Physiol. Res
, vol.44
, pp. 209-216
-
-
Rauchová, H.1
Drahota, Z.2
Lenaz, G.3
-
10
-
-
80052211991
-
Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues
-
Orsucci, D., Mancuso, M., Lenco, E. C., LoGerfo, A. & Siciliano, G. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Curr. Med. Chem. 18, 4053-4064 (2011
-
(2011)
Curr. Med. Chem
, vol.18
, pp. 4053-4064
-
-
Orsucci, D.1
Mancuso, M.2
Lenco, E.C.3
LoGerfo, A.4
Siciliano, G.5
-
11
-
-
79957829839
-
Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging
-
Shrader, W. D. et al. α-Tocotrienol quinone modulates oxidative stress response and the biochemistry of aging. Bioorg. Med. Chem. Lett. 21, 3693-3698 (2011
-
(2011)
Bioorg. Med. Chem. Lett
, vol.21
, pp. 3693-3698
-
-
Shrader, W.D.1
-
12
-
-
0024317560
-
Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndromes associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy
-
Shoffner, J. M. et al. Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndromes associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy. Proc. Natl Acad. Sci. USA 86, 7952-7956 (1989
-
(1989)
Proc. Natl Acad. Sci. USA
, vol.86
, pp. 7952-7956
-
-
Shoffner, J.M.1
-
13
-
-
0021449807
-
31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle
-
Eleff, S. et al. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc. Natl Acad. Sci. USA 81, 3529-3533 (1984
-
(1984)
Proc. Natl Acad. Sci. USA
, vol.81
, pp. 3529-3533
-
-
Eleff, S.1
-
14
-
-
77954455562
-
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation
-
Mancuso, M. et al. Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation. J. Neurol. 257, 774-781 (2010
-
(2010)
J. Neurol
, vol.257
, pp. 774-781
-
-
Mancuso, M.1
-
15
-
-
0037241026
-
The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: A double-blind randomized crossover clinical trial
-
Liet, J. M. et al. The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: A double-blind randomized crossover clinical trial. J. Pediatr. 142, 62-66 (2003
-
(2003)
J. Pediatr
, vol.142
, pp. 62-66
-
-
Liet, J.M.1
-
16
-
-
80052800016
-
The creatine kinase system and pleiotropic effects of creatine
-
Wallimann, T., Tokarska-Schlattner, M. & Schlattner, U. The creatine kinase system and pleiotropic effects of creatine. Amino Acids 40, 1271-1296 (2011
-
(2011)
Amino Acids
, vol.40
, pp. 1271-1296
-
-
Wallimann, T.1
Tokarska-Schlattner, M.2
Schlattner, U.3
-
17
-
-
24144448004
-
Exercise training in mitochondrial myopathy: A randomized controlled trial
-
Cejudo, P. et al. Exercise training in mitochondrial myopathy: A randomized controlled trial. Muscle Nerve 32, 342-350 (2005
-
(2005)
Muscle Nerve
, vol.32
, pp. 342-350
-
-
Cejudo, P.1
-
18
-
-
13844321746
-
L-Arginine improves the symptoms of strokelike episodes in MELAS
-
Koga, Y. et al. L-Arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64, 710-712 (2005
-
(2005)
Neurology
, vol.64
, pp. 710-712
-
-
Koga, Y.1
-
19
-
-
84861161948
-
Steroid responsive A3243G mutation MELAS: Clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss
-
Walcott, B. P. et al. Steroid responsive A3243G mutation MELAS: Clinical and radiographic evidence for regional hyperperfusion leading to neuronal loss. Neurologist 18, 159-170 (2012
-
(2012)
Neurologist
, vol.18
, pp. 159-170
-
-
Walcott, B.P.1
-
20
-
-
77956393641
-
Mitochondrial myopathies: Developments in treatment
-
Hassani, A., Horvath, R. & Chinnery, P. F. Mitochondrial myopathies: Developments in treatment. Curr. Opin. Neurol. 23, 459-465 (2010
-
(2010)
Curr. Opin. Neurol
, vol.23
, pp. 459-465
-
-
Hassani, A.1
Horvath, R.2
Chinnery, P.F.3
-
21
-
-
0025673969
-
Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial
-
Bresolin, N. et al. Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial. J. Neurol. Sci. 100, 70-78 (1990
-
(1990)
J. Neurol. Sci
, vol.100
, pp. 70-78
-
-
Bresolin, N.1
-
22
-
-
76349123010
-
Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade
-
Kerr, D. S. Treatment of mitochondrial electron transport chain disorders: A review of clinical trials over the past decade. Mol. Genet. Metab. 99, 246-255 (2010
-
(2010)
Mol. Genet. Metab
, vol.99
, pp. 246-255
-
-
Kerr, D.S.1
-
23
-
-
84881372228
-
-
online
-
CureMito [online], http://curemito.org/ (2012
-
(2012)
Cure Mito
-
-
-
25
-
-
4744357401
-
Chronic treatment of mitochondrial disease patients with dichloroacetate
-
Barshop, B. A. et al. Chronic treatment of mitochondrial disease patients with dichloroacetate. Mol. Genet. Metab. 83, 138-149 (2004
-
(2004)
Mol. Genet. Metab
, vol.83
, pp. 138-149
-
-
Barshop, B.A.1
-
26
-
-
84869874364
-
Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI 743 in patients with mitochondrial disease
-
Blankenberg, F. G. et al. Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI 743 in patients with mitochondrial disease. Mol. Genet. Metab. 107, 690-699 (2012
-
(2012)
Mol. Genet. Metab
, vol.107
, pp. 690-699
-
-
Blankenberg, F.G.1
-
27
-
-
0027459172
-
Plasma carnitine insufficiency and effectiveness of l carnitine therapy in patients with mitochondrial myopathy
-
Campos, Y. et al. Plasma carnitine insufficiency and effectiveness of l carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 16, 150-153 (1993
-
(1993)
Muscle Nerve
, vol.16
, pp. 150-153
-
-
Campos, Y.1
-
28
-
-
0030612535
-
Coenzyme Q10 treatment in mitochondrial encephalomyopathies Short-term double-blind, crossover study
-
Chen, R. S., Huang, C. C. & Chu, N. S. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur. Neurol. 37, 212-218 (1997
-
(1997)
Eur. Neurol
, vol.37
, pp. 212-218
-
-
Chen, R.S.1
Huang, C.C.2
Chu, N.S.3
-
29
-
-
0029072626
-
Short-term dichloracetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders
-
De Stefano, N. et al. Short-term dichloracetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45, 1193-1198 (1995
-
(1995)
Neurology
, vol.45
, pp. 1193-1198
-
-
De Stefano, N.1
-
30
-
-
1942537035
-
Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism
-
Duncan, G. E., Perkins, L. A., Theriaque, D. W., Neiberger, R. E. & Stacpoole, P. W. Dichloroacetate therapy attenuates the blood lactate response to submaximal exercise in patients with defects in mitochondrial energy metabolism. J. Clin. Endocrinol. Metab. 89, 1733-1738 (2004
-
(2004)
J. Clin. Endocrinol. Metab
, vol.89
, pp. 1733-1738
-
-
Duncan, G.E.1
Perkins, L.A.2
Theriaque, D.W.3
Neiberger, R.E.4
Stacpoole, P.W.5
-
31
-
-
84855355930
-
Initial experience in the treatment of inherited mitochondrial disease with EPI 743
-
Enns, G. M. et al. Initial experience in the treatment of inherited mitochondrial disease with EPI 743. Mol. Genet. Metab. 105, 91-102 (2012
-
(2012)
Mol. Genet. Metab
, vol.105
, pp. 91-102
-
-
Enns, G.M.1
-
32
-
-
78149325680
-
A randomized trial of coenzyme Q10 in mitochondrial disorders
-
Glover, E. I. et al. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve 42, 739-748 (2010
-
(2010)
Muscle Nerve
, vol.42
, pp. 739-748
-
-
Glover, E.I.1
-
33
-
-
0029948495
-
Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6 month therapy study with coenzyme Q
-
Gold, R. et al. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: Results of a 6 month therapy study with coenzyme Q. Eur. Neurol. 36, 191-196 (1996
-
(1996)
Eur. Neurol
, vol.36
, pp. 191-196
-
-
Gold, R.1
-
34
-
-
33646202306
-
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
-
Kaufmann, P. et al. Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology 66, 324-330 (2006
-
(2006)
Neurology
, vol.66
, pp. 324-330
-
-
Kaufmann, P.1
-
35
-
-
0034642154
-
A placebo-controlled crossover trial of creatine in mitochondrial diseases
-
Klopstock, T. et al. A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology 55, 1748-1751 (2000
-
(2000)
Neurology
, vol.55
, pp. 1748-1751
-
-
Klopstock, T.1
-
36
-
-
80052959702
-
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy
-
Klopstock, T. et al. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 134, 2677-2686 (2011
-
(2011)
Brain
, vol.134
, pp. 2677-2686
-
-
Klopstock, T.1
-
37
-
-
0037066134
-
Effects of l arginine on the acute phase of strokes in three patients with MELAS
-
Koga, Y. et al. Effects of l arginine on the acute phase of strokes in three patients with MELAS. Neurology 58, 827-828 (2002
-
(2002)
Neurology
, vol.58
, pp. 827-828
-
-
Koga, Y.1
-
38
-
-
0037231131
-
Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies
-
Komura, K., Hobbiebrunken, E., Wilichowski, E. K. & Hanefeld, F. A. Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies. Pediatr. Neurol. 28, 53-58 (2003
-
(2003)
Pediatr. Neurol
, vol.28
, pp. 53-58
-
-
Komura, K.1
Hobbiebrunken, E.2
Wilichowski, E.K.3
Hanefeld, F.A.4
-
39
-
-
84867897915
-
EPI 743 reverses the progression of the pediatric mitochondrial disease-genetically defined Leigh Syndrome
-
Martinelli, D. et al. EPI 743 reverses the progression of the pediatric mitochondrial disease-genetically defined Leigh Syndrome. Mol. Genet. Metab. 107, 383-388 (2012
-
(2012)
Mol. Genet. Metab
, vol.107
, pp. 383-388
-
-
Martinelli, D.1
-
40
-
-
84975452084
-
Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?
-
Mashima, Y., Kigasawa, K., Wakakura, M & Oguchi, Y. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? J. Neuroophthalmol. 20, 166-170 (2000
-
(2000)
J. Neuroophthalmol
, vol.20
, pp. 166-170
-
-
Mashima, Y.1
Kigasawa, K.2
Wakakura, M.3
Oguchi, Y.4
-
41
-
-
0027722281
-
Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies
-
Mathews, P. M., Andermann, F., Silver, K., Karpati, G. & Arnold, D. L. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43, 2484-2490 (1993
-
(1993)
Neurology
, vol.43
, pp. 2484-2490
-
-
Mathews, P.M.1
Andermann, F.2
Silver, K.3
Karpati, G.4
Arnold, D.L.5
-
42
-
-
4444228301
-
Dichloroacetate treatment for mitochondrial cytopathy: Long-term effects in MELAS
-
Mori, M., Yamagata, T., Goto, T., Saito, S. & Momoi, M. Y. Dichloroacetate treatment for mitochondrial cytopathy: Long-term effects in MELAS. Brain Dev. 26, 453-458 (2004
-
(2004)
Brain Dev
, vol.26
, pp. 453-458
-
-
Mori, M.1
Yamagata, T.2
Goto, T.3
Saito, S.4
Momoi, M.Y.5
-
43
-
-
58849137540
-
Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia [Japanese]
-
Ogawa, T. et al. Multi-center trial on the early effects of silodosin on lower urinary tract symptoms associated with benign prostatic hyperplasia [Japanese]. Hinyokika Kiyo 54, 757-764 (2008
-
(2008)
Hinyokika Kiyo
, vol.54
, pp. 757-764
-
-
Ogawa, T.1
-
44
-
-
4344575973
-
Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases
-
Panetta, J., Smith, L. J. & Boneh, A. Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases. J. Inherit. Metab. Dis. 27, 487-498 (2004
-
(2004)
J. Inherit. Metab. Dis
, vol.27
, pp. 487-498
-
-
Panetta, J.1
Smith, L.J.2
Boneh, A.3
-
45
-
-
0037159183
-
Ubiquinone and nicotinamide treatment of patients with the 3243A ->G mtDNA mutation
-
Remes, A. M. et al. Ubiquinone and nicotinamide treatment of patients with the 3243A ->G mtDNA mutation. Neurology 59, 1275-1277 (2002
-
(2002)
Neurology
, vol.59
, pp. 1275-1277
-
-
Remes, A.M.1
-
46
-
-
33847000236
-
Beneficial effects of creatine CoQ10, and lipoic acid in mitochondrial disorders
-
Rodriguez, M. C. et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35, 235-242 (2007
-
(2007)
Muscle Nerve
, vol.35
, pp. 235-242
-
-
Rodriguez, M.C.1
-
47
-
-
84858599179
-
Effect of EPI 743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy
-
Sadun, A. A. et al. Effect of EPI 743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy. Arch. Neurol. 69, 331-338 (2012
-
(2012)
Arch. Neurol
, vol.69
, pp. 331-338
-
-
Sadun, A.A.1
-
48
-
-
40849131523
-
Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate
-
Stacpoole, P. W. et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 121, e1223-e1228 (2008
-
(2008)
Pediatrics
, vol.121
-
-
Stacpoole, P.W.1
-
49
-
-
33646830260
-
Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children
-
Stacpoole, P. W. et al. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 117, 1519-1531 (2006
-
(2006)
Pediatrics
, vol.117
, pp. 1519-1531
-
-
Stacpoole, P.W.1
-
50
-
-
0031596402
-
The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation
-
Suzuki, S. et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 41, 584-588 (1998
-
(1998)
Diabetologia
, vol.41
, pp. 584-588
-
-
Suzuki, S.1
-
51
-
-
33845285545
-
Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions
-
Taivassalo, T. et al. Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions. Brain 129, 3391-3401 (2006
-
(2006)
Brain
, vol.129
, pp. 3391-3401
-
-
Taivassalo, T.1
-
52
-
-
0030731246
-
Randomised control trial of creatine monohydrate in patients with mitochondrial cytopathies
-
Tarnopolsky, M. A., Roy, B. D. & MacDonald, J. R. Randomised control trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20, 1502-1509 (1997
-
(1997)
Muscle Nerve
, vol.20
, pp. 1502-1509
-
-
Tarnopolsky, M.A.1
Roy, B.D.2
MacDonald, J.R.3
-
53
-
-
0029914622
-
Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control
-
Jadad, A. R. et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control. Clin. Trials 17, 1-12 (1996
-
(1996)
Clin. Trials
, vol.17
, pp. 1-12
-
-
Jadad, A.R.1
-
54
-
-
80051478879
-
Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study
-
Mazzone, E. et al. Functional changes in Duchenne muscular dystrophy: A 12-month longitudinal cohort study. Neurology 77, 250-256 (2011
-
(2011)
Neurology
, vol.77
, pp. 250-256
-
-
Mazzone, E.1
-
55
-
-
75849124774
-
-
US National Library Of Medicine gov [online]
-
US National Library of Medicine. ClinicalTrials.gov [online], http://clinicaltrials.gov/ct2/show/NCT00432744?term=NCT00432744&rank=1 (2013
-
(2013)
Clinical Trials
-
-
-
57
-
-
34548606803
-
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial
-
Di Prospero, N. A., Baker, A., Jeffries, N. & Fischbeck, K. H. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: A randomised, placebo-controlled trial. Lancet Neurol. 6, 878-886 (2007
-
(2007)
Lancet Neurol
, vol.6
, pp. 878-886
-
-
Di Prospero, N.A.1
Baker, A.2
Jeffries, N.3
Fischbeck, K.H.4
-
58
-
-
77955450939
-
A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia
-
Lynch, D. R., Perlman, S. L. & Meier, T. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia. Arch. Neurol. 67, 941-947 (2010
-
(2010)
Arch. Neurol
, vol.67
, pp. 941-947
-
-
Lynch, D.R.1
Perlman, S.L.2
Meier, T.3
-
59
-
-
79952451186
-
Idebenone in Friedreich ataxia cardiomyopathy-results from a 6 month phase III study (IONIA
-
Lagedrost, S. J. et al. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6 month phase III study (IONIA). Am. Heart J. 161, 639.e1-645.e1 (2011
-
(2011)
Am. Heart J.
, vol.161
-
-
Lagedrost, S.J.1
-
60
-
-
84864039693
-
Antioxidants and other pharmacological treatments for Friedreich ataxia
-
Kearney, M., Orrell, R. W., Fahey, M. & Pandolfo, M. Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD007791. http://onlinelibrary.wiley.com/ doi/10.1002/14651858.CD007791.pub3/abstract.
-
Cochrane Database of Systematic Reviews
-
-
Kearney, M.1
Orrell, R.W.2
Fahey, M.3
Pandolfo, M.4
-
61
-
-
84876326795
-
-
CATENA® (idebenone)-voluntary withdrawal of CATENA® from the Canadian market [online]
-
CATENA® (idebenone) - voluntary withdrawal of CATENA® from the Canadian market. Health Canada [online]. http://healthycanadians.gc.ca/recall- alert-rappel-avis/hc-sc/2013/23509a-eng.php (2013
-
(2013)
Health Canada
-
-
-
62
-
-
39649084919
-
The FDA critical path initiative and its influence on new drug development
-
Woodcock, J. & Woosley, R. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 59, 1-12 (2008
-
(2008)
Annu. Rev. Med
, vol.59
, pp. 1-12
-
-
Woodcock, J.1
Woosley, R.2
-
63
-
-
84880173824
-
Towards the harmonization of outcome measures in children with mitochondrial disorders
-
Koene, S. et al. Towards the harmonization of outcome measures in children with mitochondrial disorders. Dev. Med. Child. Neurol. http://dx.doi.org/10.1111/dmcn.12119.
-
Dev. Med. Child. Neurol
-
-
Koene, S.1
-
64
-
-
84873316509
-
Developing outcome measures for pediatric mitochondrial disorders: Which complaints and limitations are most burdensome to patients and their parents?
-
Koene, S et al. Developing outcome measures for pediatric mitochondrial disorders: Which complaints and limitations are most burdensome to patients and their parents? Mitochondrion 13, 15-24 (2013
-
(2013)
Mitochondrion
, vol.13
, pp. 15-24
-
-
Koene, S.1
-
65
-
-
33845288002
-
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
-
Jeppesen, T. D. et al. Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy. Brain 129, 3402-3412 (2006
-
(2006)
Brain
, vol.129
, pp. 3402-3412
-
-
Jeppesen, T.D.1
-
66
-
-
65349108095
-
Orphan drug development is not taking off
-
Joppi, R., Bertele, V. & Garattini, S. Orphan drug development is not taking off. Br. J. Clin. Pharmacol. 67, 494-502 (2009
-
(2009)
Br. J. Clin. Pharmacol
, vol.67
, pp. 494-502
-
-
Joppi, R.1
Bertele, V.2
Garattini, S.3
-
70
-
-
71749103033
-
Translation of rare disease research into orphan drug development: Disease matters
-
Heemstra, H. E., van Weely, S., Büller, H. A., Leufkens, H. G. & de Vrueh, R. L. Translation of rare disease research into orphan drug development: Disease matters. Drug Discov. Today 14, 1166-1173 (2009
-
(2009)
Drug Discov. Today
, vol.14
, pp. 1166-1173
-
-
Heemstra, H.E.1
Van Weely, S.2
Büller, H.A.3
Leufkens, H.G.4
De Vrueh, R.L.5
-
71
-
-
0029135075
-
CPEO and carnitine deficiency overlapping in MELAS syndrome
-
Hsu, C. C. et al. CPEO and carnitine deficiency overlapping in MELAS syndrome. Acta Neurol. Scand. 92, 252-255 (1995
-
(1995)
Acta Neurol. Scand
, vol.92
, pp. 252-255
-
-
Hsu, C.C.1
-
72
-
-
0030853576
-
Metabolic interventions against complex I deficiency in MELAS syndrome
-
Majamaa, K., Rusanen, H., Remes, A. & Hassinen, I. E. Metabolic interventions against complex I deficiency in MELAS syndrome. Mol. Cell Biochem. 174, 291-296 (1997
-
(1997)
Mol. Cell Biochem
, vol.174
, pp. 291-296
-
-
Majamaa, K.1
Rusanen, H.2
Remes, A.3
Hassinen, I.E.4
-
73
-
-
20144387513
-
Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: A placebo-controlled, double-blind 31P-MRS crossover study
-
Kornblum, C. et al. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: A placebo-controlled, double-blind 31P-MRS crossover study. Eur. J. Neurol. 12, 300-309 (2005
-
(2005)
Eur. J. Neurol
, vol.12
, pp. 300-309
-
-
Kornblum, C.1
-
74
-
-
0029164362
-
Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy
-
Barbiroli, B. et al. Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy. J. Neurol. 242, 472-477 (1995
-
(1995)
J. Neurol
, vol.242
, pp. 472-477
-
-
Barbiroli, B.1
-
75
-
-
0001179515
-
Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies
-
Taivassalo, T. et al. Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies. Neurology 48, A214 (1997
-
(1997)
Neurology
, vol.48
-
-
Taivassalo, T.1
-
76
-
-
0029658242
-
A novel heteroplasmic tRNAleu(UUR) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in muscle and suggests an approach to therapy
-
Fu, K. et al. A novel heteroplasmic tRNAleu(UUR) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in muscle and suggests an approach to therapy. Hum. Mol. Genet. 5, 1835-1840 (1996
-
(1996)
Hum. Mol. Genet
, vol.5
, pp. 1835-1840
-
-
Fu, K.1
-
77
-
-
0030926104
-
Correction of a mitochondrial DNA defect in human skeletal muscle
-
Clark, K. et al. Correction of a mitochondrial DNA defect in human skeletal muscle. Nat. Genet. 16, 222-224 (1997
-
(1997)
Nat. Genet
, vol.16
, pp. 222-224
-
-
Clark, K.1
|